Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking

Rashedul Hasan

Articles by Rashedul Hasan

Banach Fig 1.png

Barriers and Solutions to Smart Clinical Program Designs

ByHon-Sum Ko,Ian Fisher,Rashedul Hasan,Laszlo Vasko,Courtland E. Yockey,Mitra Rocca,Maria Benjegård,Johann Proeve,Dale Plummer,Steven Hirschfeld,Kerstin Forsberg,Mary Banach

April 1st 2018

Applied Clinical Trials

How the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."

Banach Fig 4.png

Barriers and Solutions to Smart Clinical Program Designs

ByHon-Sum Ko,Ian Fisher,Rashedul Hasan,Laszlo Vasko,Courtland E. Yockey,Mitra Rocca,Maria Benjegård,Johann Proeve,Dale Plummer,Steven Hirschfeld,Kerstin Forsberg,Mary Banach

November 9th 2017

Applied Clinical Trials

How the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."

Latest Updated Articles

Barriers and Solutions to Smart Clinical Program Designs
November 9th 2017
Barriers and Solutions to Smart Clinical Program Designs
April 1st 2018

Trending on Applied Clinical Trials Online

Real-World Evidence Is Moving Upstream: Is the Data Infrastructure Ready?

Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It

The Data Inputs That Matter Most When Pressure-Testing a Protocol's Feasibility

ACT Brief: AI Expands Endpoint Options, CRO Oversight Documentation, and Kidney Cancer Approval

ACT Brief: Trial Simulations and Protocol Risk, RBQM Financial Value Quantified, and Three Drug Approvals